What 6 Analyst Ratings Have To Say About Bristol-Myers Squibb

Loading...
Loading...

Over the past 3 months, 6 analysts have published their opinion on Bristol-Myers Squibb BMY stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 0 2 3 1 0
Last 30D 0 0 1 0 0
1M Ago 0 0 0 0 0
2M Ago 0 1 1 0 0
3M Ago 0 1 1 1 0

In the last 3 months, 6 analysts have offered 12-month price targets for Bristol-Myers Squibb. The company has an average price target of $75.83 with a high of $88.00 and a low of $60.00.

Below is a summary of how these 6 analysts rated Bristol-Myers Squibb over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock and the greater the number of bearish ratings, the more negative analysts are on the stock

This average price target has increased by 1.92% over the past month.

Stay up to date on Bristol-Myers Squibb analyst ratings.

Analyst Ratings: What Are They?

Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter.

Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Loading...
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst RatingsBZI-AAR
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...